3.0000
-0.3200
(-9.64%)
At close: January 28 at 8:13:01 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-12,959.0000
-12,959.0000
-13,051.0000
18,970.0000
-2,478.0000
Investing Cash Flow
-88.0000
-88.0000
-137.0000
-212.0000
-34.0000
Financing Cash Flow
-1,967.0000
-1,967.0000
22,149.0000
180.0000
1,277.0000
End Cash Position
20,211.0000
20,211.0000
34,396.0000
24,710.0000
4,538.0000
Capital Expenditure
-88.0000
-88.0000
-137.0000
-213.0000
-35.0000
Issuance of Capital Stock
127.0000
127.0000
25,544.0000
--
2.0000
Issuance of Debt
--
--
--
482.0000
63.0000
Repayment of Debt
-474.0000
-474.0000
-191.0000
--
--
Free Cash Flow
-13,047.0000
-13,047.0000
-13,188.0000
18,757.0000
-2,513.0000
12/31/2020 - 2/21/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNG.L Synairgen plc
2.4050
0.00%
SLXN Silexion Therapeutics Corp
1.3500
+132.76%
GLSI Greenwich LifeSciences, Inc.
13.13
-1.13%
QLGN Qualigen Therapeutics, Inc.
3.1200
-22.00%
REVB Revelation Biosciences, Inc.
4.2400
+11.16%
LTRN Lantern Pharma Inc.
4.7000
+2.40%
CNSP CNS Pharmaceuticals, Inc.
0.1036
+3.91%
CERO CERo Therapeutics Holdings, Inc.
1.8300
-2.14%
MBIO Mustang Bio, Inc.
4.2300
+1.68%
ALLR Allarity Therapeutics, Inc.
1.4400
-6.49%